Risperidone, a new antipsychotic with serotonin 5-HT2 and dopamine D2 antagonistic properties.
Heylen
S L
SL
Janssen Research Foundation, Dept. Clinical R&D CNS, Beerse, Belgium.
Gelders
Y G
YG
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D018492:Dopamine Antagonists; D004311:Double-Blind Method; D004562:Electrocardiography; D006801:Humans; D007555:Isoxazoles / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D017448:Receptors, Dopamine D2; D018967:Risperidone; D012559:Schizophrenia / Q000188:drug therapy*; D012702:Serotonin Antagonists
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D007555:Isoxazoles; D010880:Piperidines; D017448:Receptors, Dopamine D2; D012702:Serotonin Antagonists; D018967:Risperidone